Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AEHR TEST SYSTEMS
Report date September 02, 2020 · Filed September 03, 2020
Section 16 reporting ended · disclosed 2020-09-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,488 |
Ending reported balance
After 2020-09-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2020-09-02 · Exercise / conversion · Acquired 14,175 · Balance 15,663 Row 2 · 2020-09-02 · Exercise / conversion · Acquired 4,791 · Balance 20,454 Row 3 · 2020-09-02 · Sale · Disposed 10,000 · Balance 10,454 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.77 to $1.84, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Row 4 · 2020-09-02 · Sale · Disposed 8,966 · Balance 1,488 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.83, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. |
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.64 · Expires 2020-09-05 | Direct | 18,209 |
Reported balance
After 2020-09-02 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-09-02 · Exercise / conversion · Disposed 4,791 · Balance 18,209 F3: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.68 · Expires 2020-09-05 | Direct | 625 |
Reported balance
After 2020-09-02 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-09-02 · Exercise / conversion · Disposed 14,175 · Balance 625 F3: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.77 to $1.84, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.83, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
F3: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2020 Filed Sep 3, 2020 01:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 14,175 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001654954-20-009779 · section16.xml · derivative · entry 6 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625 Underlying: Common Stock · 14,175 shares Expires 2020-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 01:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 4,791 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-20-009779 · section16.xml · derivative · entry 5 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,209 Underlying: Common Stock · 4,791 shares Expires 2020-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 01:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 8,966 | $1.81 | $16,228.46 |
DisclosureSEC source: 0001654954-20-009779 · section16.xml · nonDerivative · entry 4 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.83, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 01:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 10,000 | $1.80 | $18,000.00 |
DisclosureSEC source: 0001654954-20-009779 · section16.xml · nonDerivative · entry 3 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,454 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.77 to $1.84, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 01:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 4,791 | $1.64 | $7,833.29 |
DisclosureSEC source: 0001654954-20-009779 · section16.xml · nonDerivative · entry 2 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 01:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 14,175 | $1.68 | $23,814.00 |
DisclosureSEC source: 0001654954-20-009779 · section16.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 23:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 200 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001654954-20-009368 · section16.xml · derivative · entry 3 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,800 Underlying: Common Stock · 200 shares Expires 2020-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 23:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 200 | $2.10 | $420.00 |
DisclosureSEC source: 0001654954-20-009368 · section16.xml · nonDerivative · entry 2 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488 Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 23:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 200 | $1.68 | $336.00 |
DisclosureSEC source: 0001654954-20-009368 · section16.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 547 | $1.52 | $831.55 |
DisclosureSEC source: 0001654954-20-005520 · section16.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488 Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 23:32 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 546 | $2.00 | $1,092.05 |
DisclosureSEC source: 0001654954-20-001350 · section16.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,035 Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 01:24 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,186 | $2.01 | $4,394.08 |
DisclosureSEC source: 0001654954-19-012762 · section16.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,581 Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 00:38 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantIncentive Stock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000011 · primary_doc.xml · derivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 01:21 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 547 | $2.01 | $1,099.47 |
DisclosureSEC source: 0001040470-18-000058 · primary_doc.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,767 Read SEC document |
| November 05, 2018 Filed Nov 6, 2018 01:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 82 | $2.01 | $164.82 |
DisclosureSEC source: 0001040470-18-000057 · primary_doc.xml · nonDerivative · entry 2 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,314 Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 01:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 464 | $2.00 | $928.00 |
DisclosureSEC source: 0001040470-18-000057 · primary_doc.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,396 Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 01:25 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantIncentive Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001040470-18-000046 · primary_doc.xml · derivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2025-08-17 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| May 08, 2018 Filed May 10, 2018 22:07 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,890 | $2.38 | $6,878.20 |
DisclosureSEC source: 0001040470-18-000027 · primary_doc.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,860 Read SEC document |
| July 11, 2017 Filed Jul 13, 2017 22:51 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantIncentive Stock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001040470-17-000044 · primary_doc.xml · derivative · entry 2 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2024-07-11 F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 11, 2017 Filed Jul 13, 2017 22:51 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-17-000044 · primary_doc.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
| October 19, 2016 Filed Jan 25, 2017 23:56 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 3,542 | $2.90 | $10,255.51 |
DisclosureSEC source: 0001040470-17-000007 · primary_doc.xml · nonDerivative · entry 2 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| October 17, 2016 Filed Jan 25, 2017 23:56 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 7,618 | $2.85 | $21,711.30 |
DisclosureSEC source: 0001040470-17-000007 · primary_doc.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,542 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.